Mood disorders in patients with COPD: overview of current research and future needs

References

• Breslau N, Johnson EQ. Predicting smoking cessation and major depression in nicotine dependent smokers. Am. j Public Health 90(7), 1122–1127 (2000).
   PubMed Web of Science ®Google Scholar
• Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch. Gen. fiychiatry 59(2), 129–130 (2002).
   Google Scholar
• Gulsvik A. The global burden and the impact of chronic obstructive lung disease worldwide. Menai& Arch. Chest. Dis 56(3), 261–264 (2001).
   Google Scholar
• Mayer AS, Newman LS. Genetic and environmental modulation of chronic obstructive pulmonary disease. Rept: Physiol 128(1), 3–11 (2001).
   Google Scholar
• Black DW, Zimmerman M, Coryell WH. Cigarette smoking and psychiatric disorder in a community sample. Ann. Clin. PTchiatry 11(3), 129–136 (1999).
   Google Scholar
• Smith SS, Fiore MC. The epidemiology of tobacco use, dependence and cessation in the United States. Primary Care. Clin. Office Prac. North Am 26(3), 433–461 (1999).
   Google Scholar
• Kim HF, Kunik ME, Molinari VA et al Functional impairment in COPD patients: the impact of anxiety and depression. PTchosomatics 41(6), 465–471 (2000).
   PubMed Web of Science ®Google Scholar
• Gift AG, McCrane SH. Depression in patients with COPD. Heart Lung-22(4), 289–297 (1993).
   PubMed Web of Science ®Google Scholar
• Light RVV, Merrill EJ, Despars JA, Gordon GH, Mutalipassi LR. Prevalence of depression in patients with COPD. Relationship to functional capacity. Chest 87(1), 35–38 (1985).
   Google Scholar
• •One of the first papers to bring out the increased comorbidity of COPD and depression.
   Google Scholar
• Van Schayack CR Measurement of quality of life in patients with chronic obstructive pulmonary disease. PhalmacoEconomics 11 (1), 13–18 (1997). itStang P, Lydick E, Silberman C, Kempel A, Keating ET The prevalence of COPD using smoking rates to estimate disease frequency in the general population. Chest 117(5 Suppl. 2), 354S-359S (2000).
   Google Scholar
• Sethi JM, Rochester CL. Smoking and chronic obstructive pulmonary disease. Clin. Chest Merl North Am. 21(1), 67–86 (2000).
   Google Scholar
• Frasure-Smith N, Lesparance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 270,1819–1825 (1993).
   Google Scholar
• •Landmark article regarding the negative influence on depression when involved in coronary artery disease.
   Google Scholar
• Frasure-Smith N, Lesparance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 91,999–1005 (1995).
   Google Scholar
• •Landmark article regarding the negative influence on depression when involved in coronary artery disease.
   Google Scholar
• McSweeny AJ, Grant I, Heaton RIK, Adams KM, Timms RM. Life quality of patients with chronic obstructive pulmonary disease. Arch. Intern. Med. 142 (3), 473–478 (1987).
   Google Scholar
• Goethe JW, Maljanian R, Wolf S, Hernandez P, Cabrera Y. The impact of depressive symptoms on the functional status of inner-city patients with asthma. Ann. Allergy Asthma 'minimal 87(3), 205–210 (2001).
   Google Scholar
• Singer HK, Ruchinskas RA, Riley KC, Broshek DK, Barth JT. The psychological impact of end stage lung disease. Chest 120(4), 1246–1252 (2001).
   Google Scholar
• Felker B, IKaton W Hedrick SC eta] The association between depressive symptoms and health status in patients with chronic obstructive pulmonary disease. Gen. Hosp. PTchiatry23(2), 56–61 (2001).
   Google Scholar
• Steffens DC, Krishnan KR, Helm MJ. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta analysis. Depress. Anxiety6(1), 10–18 (1997).
   Google Scholar
• Jiang W Alexander J, Christopher E etal Relationship of depression to increased risk of mortality and rehospitalization with congestive heart failure. Arch. Intern. Med. 161(15), 1849–1856 (2001).
   Google Scholar
• Clary GL, Davenport C, Biracree D et al Effects of antidepressant medication on mortality in patients with congestive heart failure. American College of Cardiology, Atlanta, GA, USA, Presentation 1134–1156, Poster 156, March 17–21,2002.
   Google Scholar
• Griffith TF, IKLassen PS, Szezech LA. Selective serotonin re-uptake inhibitors as surrogates of depression in dialysis patients:observations and trends. American Society of Nephrology, Philadelphia, PA, USA, Poster SU-P0803, November 1–4, 2002.
   Google Scholar
• Jiang W, Krishnan RR, O'Connor CM. Depression and heart disease: evidence of a link and its therapeutic implications. CNS Drugs 16 (2), 111–127 (2002).
   Google Scholar
• Rovner BW. Depression and increased risk of mortality in the nursing home patient. Amj Med. 94(5A), 19S-22S (1993).
   Google Scholar
• Kessler D, Bennewith O, Lewis G, Sharp D. Detection of depression and anxiety in primary care: follow-up study. BE Med. J. 325(7371), 1016–1017 (2002).
   Google Scholar
• Viegi G, Pedreschi M, Pistelli F etal. Prevalence of airways obstruction in a general population: European Respiratory Society vs. American Thoracic Society definition. Chest 117(5 Suppl. 2), 339S-345S (2000).
   Google Scholar
• Burr ML. Epidemiology of asthma. Monogr Allergy31,80–102 (1993).
   Google Scholar
• Dahlen I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 122,1633–1637 (2002).
   PubMed Web of Science ®Google Scholar
• Nejtek VA, Brown ES, Khan DA, Moore JJ, Van Wagner J, Perantie DO. Prevalence of mood disorders and relationship to asthma severity in patients at an inner-city asthma clinic. Ann. Allergy Immunol 87(2), 129–133 (2001).
   Google Scholar
• Picado C, Montserrat JM, de Pablo J, Plaza V, Agusti-Vidal A. Predisposing factors to death after recovery from a life-threatening asthmatic attack. Asthma 26 (4), 231–236 (1989).
   Google Scholar
• Mascia A, Frank S, Berkman A eta]. Mortality versus improvement in severe chronic asthma: physiologic and psychologic factors. Ann. Allergy 62 (4), 311–317 (1989).
   Google Scholar
• Fiore MC, Hatsukami, Baker TB. Effective tobacco dependence treatment. JAMA 288(14), 1768–1771 (2002).
   Google Scholar
• Hamalainen J, IKaprio J, Isometsa E etal Cigarette smoking, alcohol intoxication and major depressive episode in a representative population sample. Health 55(8), 573–576 (2001).
   Google Scholar
• Ernst M, Heishman SJ, Spurgeon L, London ED. Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacoloy 25 (3), 313 (2001).
   Google Scholar
• Warburton DM, Mancuso G. Evaluation of the information processing and mood effects of a transdermal nicotine patch. fiychophatmacology (135 (3), 305–310 (1998).
   PubMed Web of Science ®Google Scholar
• Watkins SS, Koob GF, Markou A. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob. Res. 2(1), 19–37 (2000).
   Google Scholar
• Djuric VJ, Dunn E, Overstreet DH, Dragomir A, Stoner M. Antidepressant effect of ingested nicotine in female rats of the Flinders resistant and sensitive lines. Physiol Behav. 67(4), 533–537 (1999).
   Google Scholar
• Salin-Pascual RJ, Rosas M, Jimenez-Gendi A, Rivera-Meza BL, Delgado-Para V. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J. Clin. Psychiatry 57(9), 87–89,1996.
   Google Scholar
• Salin-Pascual RJ, Drucker-Colin R. A novel effect of nicotine on mood and sleep in major depression. Neumreport 9(1), 57–60 (1998).
   PubMedGoogle Scholar
• •Interesting early article concerning the influence of nicotine on mood-related symptoms.
   Google Scholar
• Ribeiro EB, Bettiker RL, Boganor M, Wurtman RJ. Effects of systemic nicotineon serotonin release in rat brain. Brain Res. 621(2), 311–318 (1993).
   Google Scholar
• Covey LS, Glassman AH, Stetner Cigarette smoking and major depression. J. Addict. Dis. 17(1), 35–46 (1998).
   Google Scholar
• Shytle RD, Silver AA, Lukasa RJ, Newman MB, Sheehan DV, Sanberg PR., Nicotinic acetylcholine receptors as targets for antidepressants. Mal Psychiatry 7(6), 525–535 (2002).
   PubMed Web of Science ®Google Scholar
• Stein EA, Pankiewicz J, Harsch III I et al. Nicotine—induced limbic cortical activation in the human brain: a functional MRI study. Ainj fiychiatry155 (8), 1009–1015 (1998).
   PubMed Web of Science ®Google Scholar
• Mihailescu S, Guzman-Marin R, Dominguez Mdel C, Drucker-Colin R. Mechanisms of nicotine actions on dorsal raphe serotonergic neurons. Eur. Pharmacol 452(1), 77–82 (2002).
   Google Scholar
• Covey LS, Glassman AH, Stetner F, Rivelli S, Stage K. A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. Am. J. Psychiatry159, 1731–1737 (2002).
   Google Scholar
• Seth P, Cheeta S, Tucci S, File SE. Nicotinic—serotonergic interactions in brain and behavior. Phalmacol Biochem. fkhav. 71(4), 795–805 (2002).
   Google Scholar
• Nakamura K, Kurasawa M. Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism. Eur. j Phalmacol 420(1), 33–43 (2001).
   Google Scholar
• Picciotto MR, Brunzell DH, Calderone BJ. Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 13(9), 1097–1106 (2002).
   Google Scholar
• Fowler JS, Logan J, Wang GJ etal PET imaging of monoamine oxidase B in peripheral organs in humans. J. Nucl. Merl 43(10), 1331–1338 (2002).
   Google Scholar
• Berlin I, Anthenelli RM. Monoamine oxidases and tobacco smoking. int. J. Neuropsychopharmacol 4(1), 33–42 (2001).
   Google Scholar
• Fowler JS, Wang GJ, Volkow ND etal Maintenance of brain monoamine oxidase B inhibition in smokers after overnight cigarette abstinence. Am. J. Psychiatry 157(11), 1864–1866 (2000).
   Google Scholar
• Glassman AH, Stetner F, Walsh BT et al Heavy smokers, smoking cessation and clonidine. Results of a double-blind, randomized trial. JAIVIA 259 (19), 2863–2866 (1988).
   PubMed Web of Science ®Google Scholar
• Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression follow-up study. Lancet 357(9272), 1929–1932 (2001).
   PubMed Web of Science ®Google Scholar
• •Classic article relating influence of smoking cessation on evolution of mood symptoms.
   Google Scholar
• Covey LS, Glassman AH, Stener E Major depression following smoking cessation. Am. fiychtry154(2), 263–265 (1997).
   PubMed Web of Science ®Google Scholar
• Salin-Pascual RJ. Relationship between mood improvement and sleep changes with acute nicotine administration in non-smoking major depression patients. Rev Invest. Clin. 54(1), 36–40 (2002).
   Google Scholar
• Glassman AH, O'Connor, Califf RM and the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAIVIA 288(6), 701–709 (2002).
   PubMed Web of Science ®Google Scholar
• Borson S, Claypoole, K, McDonald GJ. Depression and chronic obstructive pulmonary disease: treatment trials. Semin. Neuropsychiatry3(2), 115–130 (1998).
   PubMedGoogle Scholar
• Greenberg HE, Scharf SM, Green H. Nortriptyline-induced depression of ventilatory control in a patient with chronic obstructive pulmonary disease. Am Rev Respir. Dis. 147(5), 1303–1305 (1993).
   Google Scholar
• Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, Van Tuinen C. Improvement in mood, physical symptoms and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 33(2), 190–201 (1992).
   PubMed Web of Science ®Google Scholar
• Ferguson GT. Update on pharmacologic therapy for chronic obstructive pulmonary disease. Clin. Chest Merl North Am. 21 (4), 723–738 (2000).
   Google Scholar
• CAST II Investigators. Preliminary report: effect of encainide and flecanide in mortality in a randomized trial of arrhythmia suppression after myocardial infarction. NEJM327, 227–233 (1992).
   Google Scholar
• Glassman AH, Roose SP, Bigger JT Jr. The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA 269,2673–2675 (1993).
   Google Scholar
• Roose SP, Glassman AH. Antidepressant choice in the patient with cardiac disease: lessons from the Cardiac Arrhythmia Suppression Trial (CAST). J. Clin. fiychiatry 55 (Suppl. A), 83–87 (1994) .
   Google Scholar
• Roose SR Considerations for the use of antidepressants in patients with cardiovascular disease. Am. Heart 140 (Suppl. 4), 84–88 (2000).
   Google Scholar
• Hall SM, Reus VI, Munoz RF eta]. Nortriptyline and cognitive—behavioral therapy in the treatment of cigarette smoking. Arch. Gen. Psychiati y55(8), 683–690 (1998).
   Google Scholar
• Prochazka AV, Weaver AJ, Keller RT, Fryer GE, Licari PA, Lofaso D. A randomized trial of nortriptyline for smoking cessation. Anh. Intern. Merl 158(18), 2035-2039 (1998).
   Google Scholar
• Suihara H, Ishihara K, Noguchi H. Clinical experience with amitriptyline in the treatment of bronchial asthma. Ann. Allergy 23(9), 422–429 (1965).
   Google Scholar
• Light RW, Merrill EJ, Despars J, Gordon GH, Mutalipassi LR. Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch. Intern. Merl 146(7), 137–150 (1986).
   Google Scholar
• Series F, Cormier Y. Effects of protriptyline on diurnal and nocturnal oxygenation in patients with chronic obstructive pulmonary disease. Ann. Intern Med. 113(7), 507–511 (1990).
   PubMed Web of Science ®Google Scholar
• Series F, Marc I, Cormier Y, LaForge J. Long-term effects of protriptyline in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 147(6 Pt 1), 1487–1490 (1993).
   Google Scholar
• Strom K, Boman G, Petersen K etal Effect of protriptyline 10 mg daily, on chronic hypoxemia in chronic obstructive pulmonary disease. Eur. Respir. J. 8 (3), 425–459 (1995).
   Google Scholar
• Rose JE. Nicotine addiction and treatment. Ann. Rev Merl 47,493–507 (1996).
   Google Scholar
• Chengappa KN, Kambhampati RK, Perkins K etal Bupropion sustained release as smoking cessation treatment in remitted depressed patients maintained on treatment. J. Clin. fiychiatry62 (7), 503–508 (2001).
   Google Scholar
• Gonzales DH, Nides MA, Ferry LH etal Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion. a randomized placebo-controlled study. Clin. Pharmacol Ther. 69(6), 438–444 (2001).
   Google Scholar
• Roose SP, Spatz E. Treatment of depression in patients with heart disease. J. Clin. fisychiatry60\(Suppl. 20) 34–37 (1999).
   Google Scholar
• Patten CA, Rummans TA, Croghan IT, Hurt RD, Hays JT. Development of depression during placebo-controlled trials of bupropion for smoking cessation. J. Clin. Psychiatry60(7), 436–441 (1999).
   Google Scholar
• Papp LA, Weis JR, Greenberg HE etal Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. Am. J. Psychiatry 152(10), 1531 (1995).
   Google Scholar
• Smoller JW, Pollack MET, Systrom D, Kradin RL. Sertraline effects on dyspnea in patients with chronic obstructive pulmonary disease. Psychosomatics 3.9(1), 24–29 (1998).
   Google Scholar
• Rampin O, Pierrfiche O, Denavit-Saubie M. Effects of serotonin and substance P on bulbar respiratory neurons in vivo. Brain Res. 17;622(1–2), 185–193 (1993).
   Google Scholar
• Palmer SM, Clary GL, Babyak MA etal 68th Annual International Scientific Assembly of American College of Chest Physicians, Poster 298, San Diego, CA, USA, November 2–7,2002.
   Google Scholar
• Thase ME, Trivedi M. Optimizing treatment outcomes for patients with depression and generalized anxiety disorder. fiychopharmacol Bull. 36\(Suppl. 2), 93–102 (2002).
   Google Scholar
• Menza MA, Kaufman KR, Castellanos A. Modafinil augmentation of antidepressant treatment in depression. j Gun. Psychiatry 61(5), 378–381 (2000).
   Google Scholar
• Artigas F, Nutt DJ, Shelton R. Mechanism of action of antidepressants. fiychopharmacol Bull. 36\(Suppl. 2),123–132 (2002).
   Google Scholar
• Roose SP, Glassman AH, Attia E, Woodring S, Giardina EG, Bigger JT Jr. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am. J fiychiatry155(5), 660–665 (1998).
   Google Scholar
• Roose SP, Glassman AH. Antidepressant choice in the patient with cardiac disease: lessons from the Cardiac Arrhythmia Suppression Trial (CAST) studies. J Gun. fiychiatry55 (Suppl. A), 83–87 (1994).
   Google Scholar
• Glassman AH, Roose SR Risks of antidepressants in the elderly: tricyclic antidepressants and arrhythmia — revising risks. Cemntology 40\(Suppl. 11), 15–20 (1994).
   Google Scholar
• Glassman AH, Roose SP, Bigger JT Jr. The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAIVIA 269(20), 2673–2675 (1993).
   Google Scholar
• Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EG. Cardiovascular effects of buproprion in depressed patients with heart disease. Am. J PTchiatry148(4), 512–516 (1991).
   PubMed Web of Science ®Google Scholar
• Steens RD, Pouliot Z, Millar TW, Kryger MH, George CE Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. Sleep 16(4), 318–326 (1993).
   Google Scholar
• Murciano D, Armengaud MET, Cramer PH etal Acute effects of zolpidem, triazolam and flunitrazepam on arterial blood gases and control of breathing in severe COPD. Eur Respir. 6(5), 625–629 (1993).
   Google Scholar
• Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE. Bronchodilator, cardiovascular and hypokalemic effects of fenoterl, salbutamol and terbutaline in asthma. Lancet 336(8728), 1396–1399 (1990).
   Google Scholar
• Furukawa CT, DuHamel TR, Weimer L, Shapiro GG, Pierson WE, Bierman CW. Cognitive and behavioral findings in children taking theophylline. J. Allergy Clin. Immunol 81(1), 83–88 (1988).
   Google Scholar
• Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin. Pharmacokinet. 36(6), 425–438 (1999).
   Google Scholar
• Wada K, Yamada N, Sato T etal Corticosteroid-induced psychotic and mood disorders. PTchosomatics 42,461–466 (2001).
   PubMedGoogle Scholar
• Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. int. Ceriatr PTchiatry16(5), 451–454 (2000).
   Google Scholar
• Van den Breckel AM, Harrington L. Toxic effects of theophylline caused by fluvoxamine. CM4J1,151(9), 1289–1290 (1994).
   Google Scholar
• Sramek JJ, Zarotsky V, Cutler NR. Generalized anxiety disorder: treatment options. Drugs 62 (11),1635–164 8 (2002).
   Google Scholar